NCT06600321 2026-02-17A Study to Evaluate ALN-BCAT in Patients With Hepatocellular CarcinomaAlnylam PharmaceuticalsPhase 1 Recruiting158 enrolled
NCT06352528 2025-10-06A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic ImpairmentBristol-Myers SquibbPhase 1 Completed18 enrolled